Publikation
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.
Wissenschaftlicher Artikel/Review - 28.08.2022
Addeo Alfredo, Rothschild Sacha I, Holer Lisa, Schneider Martina, Waibel Christine, Haefliger Simon, Mark Michael, Fernandez Eugenio, Mach Nicolas, Mauti Laetitia, Jermann Philip, Alborelli Ilaria, Calgua Byron, Savic-Prince Spasenija, Joerger Markus, Früh Martin
Addeo, Alfredo
5
0
Rothschild, Sacha I
21
0
Holer, Lisa
1
0
Schneider, Martina
3
0
Waibel, Christine
2
0
Haefliger, Simon
2
0
Mark, Michael
13
0
Fernandez, Eugenio
1
0
Mach, Nicolas
11
0
Mauti, Laetitia
2
0
Jermann, Philip
2
0
Alborelli, Ilaria
2
0
Calgua, Byron
1
0
Savic-Prince, Spasenija
1
0
Joerger, Markus
8
0
Früh, Martin
Stv. ChefarztLeitung Fachbereich Onkologie
Medizinische Onkologie und Hämatologie · Dept. I
124
37